153 related articles for article (PubMed ID: 38131055)
1. Consumer perception, knowledge, and uses of cannabidiol.
Nguyen C; Moeller KE; McGuire M; Melton BL
Ment Health Clin; 2023 Oct; 13(5):217-224. PubMed ID: 38131055
[TBL] [Abstract][Full Text] [Related]
2. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021.
Geppert J; Lietzow J; Hessel-Pras S; Kirsch F; Schäfer B; Sachse B
BMC Public Health; 2023 Nov; 23(1):2318. PubMed ID: 37996800
[TBL] [Abstract][Full Text] [Related]
3. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
Wheeler M; Merten JW; Gordon BT; Hamadi H
Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
[No Abstract] [Full Text] [Related]
4. National survey identifying community pharmacist preceptors' experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products.
Nichols MA; Arnett SJ; Fa B; Marchionda RA; Cutting MC; McDonald MR; Miller ML
J Am Pharm Assoc (2003); 2021; 61(4S):S91-S104. PubMed ID: 33558186
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
6. A Cross-Sectional Study of Cannabidiol Users.
Corroon J; Phillips JA
Cannabis Cannabinoid Res; 2018; 3(1):152-161. PubMed ID: 30014038
[No Abstract] [Full Text] [Related]
7. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Goodman S; Wadsworth E; Schauer G; Hammond D
Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
[No Abstract] [Full Text] [Related]
8. The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD.
Bhamra SK; Desai A; Imani-Berendjestanki P; Horgan M
Phytother Res; 2021 Oct; 35(10):5734-5740. PubMed ID: 34350641
[TBL] [Abstract][Full Text] [Related]
9. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and Attitudes.
Schilling JM; Hughes CG; Wallace MS; Sexton M; Backonja M; Moeller-Bertram T
J Pain Res; 2021; 14():1241-1250. PubMed ID: 33981161
[TBL] [Abstract][Full Text] [Related]
11. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
McFadden BR; Malone T
Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
[TBL] [Abstract][Full Text] [Related]
12. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
Tran T; Kavuluru R
Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
[TBL] [Abstract][Full Text] [Related]
13. Young adults' knowledge, perceptions and use of cannabidiol products: a mixed-methods study.
Wysota CN; Le D; Clausen ME; Ciceron AC; Fuss C; Bennett B; Romm KF; Duan Z; Berg CJ
Health Educ Res; 2022 Nov; 37(6):379-392. PubMed ID: 36217613
[TBL] [Abstract][Full Text] [Related]
14. Alternative and Complimentary Medication Use in Singers: A Pilot Survey.
Mavraj G; Balouch B; Alnouri G; Sataloff RT
J Voice; 2022 Oct; ():. PubMed ID: 36270919
[TBL] [Abstract][Full Text] [Related]
15. Differences in Cannabidiol-Related Attitudes and Practice Behaviors Between U.S. Primary Care Physicians Practicing in a Single Health Care System Across States With and Without Marijuana Legalization.
Sharma P; Wilfahrt RP; Lackore K; Hammond CJ
Cannabis Cannabinoid Res; 2023 May; ():. PubMed ID: 37220016
[No Abstract] [Full Text] [Related]
16. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.
Li J; Carvajal R; Bruner L; Kaminski NE
Food Chem Toxicol; 2021 Nov; 157():112600. PubMed ID: 34626752
[TBL] [Abstract][Full Text] [Related]
17. Illinois Pharmacists and Over the Counter Cannabidiol Products: A Survey on Knowledge and Educational Needs.
Link K; Deshpande M; Ferguson M
Innov Pharm; 2020; 11(2):. PubMed ID: 34007603
[TBL] [Abstract][Full Text] [Related]
18. Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome.
Maertens M; Silver H; Dixon Weber J; Rosselot H; Lozano R
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140762
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 May; 22(5):556-566. PubMed ID: 33400996
[TBL] [Abstract][Full Text] [Related]
20. Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom.
Erridge S; Coomber R; Sodergren MH
J Cannabis Res; 2022 Oct; 4(1):56. PubMed ID: 36309761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
